Company Information

CIN
Status
Date of Incorporation
07 February 2005
State / ROC
Chennai / ROC Chennai
Last Balance Sheet
31 March 2020
Last Annual Meeting
31 December 2020
Paid Up Capital
169,930
Authorised Capital
169,930

Directors

Alessandro Mauro Del Fabro
Alessandro Mauro Del Fabro
Director/Designated Partner
over 2 years ago
Anandmohan Harendra Maurya
Anandmohan Harendra Maurya
Director/Designated Partner
over 2 years ago
Shriram .
Shriram .
Director/Designated Partner
about 7 years ago
Ramesh Alur
Ramesh Alur
Alternate Director
almost 15 years ago
Hemant Jalan
Hemant Jalan
Alternate Director
almost 21 years ago

Past Directors

Murali Panchapagesa Muthuswamy
Murali Panchapagesa Muthuswamy
Managing Director
about 19 years ago
Neil Goldsmith
Neil Goldsmith
Director
almost 21 years ago

Patents

Polynucleotide Associated With Sequiterpenoid Synthase And Uses Thereof

ABSTRACT “POLYNUCLEOTIDE ASSOCIATED WITH SEQUITERPENOID SYNTHASE AND USES THEREOF” The cDNA encoding a polypeptide associated with Sesquiterpenoid synthase (AiSTS) Biosynthesis is provided herein. The present disclosure also provides recombinant DNA molecule comprising the polynucleotide molecules as disclosed i...

Process For Preparation Of Diyne Compounds And Salts Thereof

The present disclosure provides process for the preparation of 14-(furan-2-yl) tetradeca-11,13-diynoic acid (14-FTDA), and salts thereof comprising: coupling of a halo-ethynyl furan with an acetylene acid having terminal alkyne, in the presence of a metal catalyst and a base, to obtain 14-(furan-2-yl) tetradeca-11,1...

Diyne Compounds And Salts Thereof, Process For Preparation Of Same And Application Thereof

The present disclosure relates to a process for preparing 14-(furan-2-yl)tetradeca-11,13-diynoic acid (14 FTDA) and salts thereof, comprising: coupling of an acetylene compound with a halo-do-dec-11-ynoic acid in presence of a metal catalyst and a base to obtain 14-(furan-2-yl)tetradeca-l 1,13-diynoic acid (14 FTDA)...

Documents

Form AOC-4-06012021_signed
Copy of Financial Staements duly authenticated as per section 134 (Including Boards report, auditors report and other documents)-31122020
Directors report as per section 134(3)-31122020
Interest in other entities;-14062019
Declaration of the appointee director, Managing director, in Form No. DIR-2;-14062019
Form DIR-12-14062019_signed
Form MGT-7-03012019_signed
Form AOC-4-03012019_signed
List of share holders, debenture holders;-31122018
Optional Attachment-(1)-31122018
Directors report as per section 134(3)-31122018
Copy of Financial Staements duly authenticated as per section 134 (Including Boards report, auditors report and other documents)-31122018
Optional Attachment-(1)-31122018
Acknowledgement received from company-14122018
Proof of dispatch-14122018
Form DIR-11-14122018_signed
Notice of resignation filed with the company-14122018
Optional Attachment-(2)-13122018
Form DIR-12-13122018_signed
Notice of resignation;-13122018
Evidence of cessation;-13122018
Optional Attachment-(1)-13122018
Declaration of the appointee director, Managing director, in Form No. DIR-2;-13122018
Form ADT-3-30102018-signed
Optional Attachment-(1)-18102018
Form DIR-12-18102018_signed
Copy of the intimation sent by company-15102018
Copy of written consent given by auditor-15102018
Copy of resolution passed by the company-15102018
Optional Attachment-(1)-15102018